List of directors and their roles and functions
Filed with HKEX · Stock code 2487 · · 1 page · English
Summary by 6ix AI
This filing is a list of directors and their roles for Cutia Therapeutics.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Earlier from Cutia Therapeutics
- Change of executive director
- 2026 Interim Report
- Voluntary announcement - CU-40102 (topical finasteride spray) obtained marketing approval by the macao pharmaceutical administration bureau
- Poll results of the annual general meeting held on 26 June 2026
Later from Cutia Therapeutics
- Voluntary announcement - share repurchase program under the share repurchase mandate
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
- Next Day Disclosure Return
- Voluntary announcement - latest update on the cooperation with rejuven
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2026
Follow Cutia Therapeutics into a list and get an email when it puts out news.
Follow Cutia Therapeutics